Endothelial-to-mesenchymal transition: Cytokine-mediated pathways that determine endothelial fibrosis under inflammatory conditions

被引:148
|
作者
Perez, Lorena [1 ,2 ,3 ]
Munoz-Durango, Natalia [3 ]
Riedel, Claudia A. [1 ,2 ,3 ]
Echeverria, Cesar [4 ]
Kalergis, Alexis M. [3 ,5 ,6 ]
Cabello-Verrugio, Claudio [1 ,2 ,3 ]
Simon, Felipe [1 ,2 ,3 ]
机构
[1] Univ Andres Bello, Fac Ciencias Biol, Dept Ciencias Biol, Ave Republ 239, Santiago 8370134, Chile
[2] Univ Andres Bello, Fac Med, Ave Republ 239, Santiago 8370134, Chile
[3] Millennium Inst Immunol & Immunotherapy, Ave Alameda 340, Santiago 8331150, Chile
[4] Univ Bernardo O Higgins, Lab Bionanotecnol, Gen Gana 1780, Santiago 8370854, Chile
[5] Pontificia Univ Catolica Chile, Fac Med, Dept Reumatol, Ave Alameda 340, Santiago 8331150, Chile
[6] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Genet Mol & Microbiol, Ave Alameda 340, Santiago 8331150, Chile
关键词
TGF-beta; TNE-alpha; Endothelium; Fibrosis; Interleukin; Inflammation; NF-KAPPA-B; TGF-BETA; CARDIAC FIBROSIS; PROGENITOR CELLS; TRANSFORMING GROWTH-FACTOR-BETA-2; PULMONARY-HYPERTENSION; RENAL FIBROSIS; POTENTIAL ROLE; IN-VITRO; PROMOTES;
D O I
10.1016/j.cytogfr.2016.09.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
During the last decade, the endothelial-to-mesenchymal transition (EndMT) process has attracted considerable attention due to associations with the onset of certain diseases, such as organ fibrosis and cancer. Several studies have assessed the mechanisms and signaling pathways that regulate endothelial fibrosis in the context of human pathologies. A number of inflammatory mediators, including pro inflammatory cytokines, growth factors, oxidative stress, and toxins, induce the conversion of endothelial cells into mesenchymal fibroblast-like cells that promote disease progression. This review is separated into five chapters that critically present current knowledge on EndMT in the context of pathology. First, the main characteristics of EndMT are summarized, with a focus on the endothelial protein pattern changes that modulate the expressions of endothelial/fibrotic markers and extracellular matrix proteins. These expressions could serve as mechanisms for explaining potential EndMT contributions to human pathologies in adults. Second, the main findings supporting a connection between EndMT-mediated endothelial fibrosis and inflammatory conditions are presented. These connections could be linked to the onset and progression of pathological conditions. Third, EndMT inducers are described in detail. This includes considerations on the actions of the first and most well-known EndMT inducer, TGF-beta; of the most prominent pro-inflammatory cytokines released during inflammation, such as IL 1-beta and TNF-alpha; and of the NF-kappa B transcription factor, a common player during inflammation-induced EndMT. Furthermore, thorough attention is given to EndMT induction by endotoxins in the context of bacterial infectious diseases. Additionally, the participation of the inflammatory oxidative stress environment in the EndMT induction was also reviewed. Fourth, the pathophysiological findings of inflammation induced EndMT are presented, and, fifth, special focus is placed on associations with cancer onset and development. Altogether, this review highlights the important role of EndMT-mediated endothelial fibrosis during inflammation in human pathologies. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:41 / 54
页数:14
相关论文
共 50 条
  • [41] Endothelial-to-Mesenchymal Transition in Atherosclerosis: Friend or Foe?
    Gole, Sarin
    Tkachenko, Svyatoslav
    Masannat, Tarek
    Baylis, Richard A.
    Cherepanova, Olga A.
    CELLS, 2022, 11 (19)
  • [42] Transforming Growth Factor β-Induced Endothelial-to-Mesenchymal Transition: A Switch to Cardiac Fibrosis?
    Goumans, Marie-Jose
    van Zonneveld, Anton Jan
    ten Dijke, Peter
    TRENDS IN CARDIOVASCULAR MEDICINE, 2008, 18 (08) : 293 - 298
  • [43] Reassessing endothelial-to-mesenchymal transition in cardiovascular diseases
    Yan Li
    Kathy O. Lui
    Bin Zhou
    Nature Reviews Cardiology, 2018, 15 : 445 - 456
  • [44] Endothelial-to-Mesenchymal Transition in Pulmonary Arterial Hypertension
    Gorelova, Anastasia
    Berman, Mariah
    Al Ghouleh, Imad
    ANTIOXIDANTS & REDOX SIGNALING, 2021, 34 (12) : 891 - 914
  • [45] Influence of melanoma cells in endothelial-to-mesenchymal transition
    Lechevalier, D.
    Platel, V.
    Le Corre, Y.
    Martin, L.
    Clere, N.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2021, 35 : 187 - 188
  • [46] Mechanisms of Endothelial-to-Mesenchymal Transition Induction by Extracellular Matrix Components in Pulmonary Fibrosis
    Grigorieva, O. A.
    Vigovskiy, M. A.
    Dyachkova, U. D.
    Basalova, N. A.
    Aleksandrushkina, N. A.
    Kulebyakina, M. A.
    Zaitsev, I. L.
    Popov, V. S.
    Efimenko, A. Yu
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2021, 171 (04) : 523 - 531
  • [47] Mechanisms of Endothelial-to-Mesenchymal Transition Induction by Extracellular Matrix Components in Pulmonary Fibrosis
    O. A. Grigorieva
    M. A. Vigovskiy
    U. D. Dyachkova
    N. A. Basalova
    N. A. Aleksandrushkina
    M. A. Kulebyakina
    I. L. Zaitsev
    V. S. Popov
    A. Yu. Efimenko
    Bulletin of Experimental Biology and Medicine, 2021, 171 : 523 - 531
  • [48] SIRT6 inhibits endothelial-to-mesenchymal transition through attenuating the vascular endothelial inflammatory response
    Chen, Lifang
    Wang, Guan
    He, Jianyu
    Yang, Xin
    Zheng, Zihan
    Deng, Ying
    Liu, Yizhen
    Chen, Danli
    Lin, Rong
    Wang, Weirong
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 101
  • [49] Editorial: Endothelial-to-mesenchymal transition in cardiovascular disease
    Alfaidi, Mabruka
    Evans, Paul C.
    Pickering, J. Geoffrey
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [50] Targeting RNA elongation in endothelial-to-mesenchymal transition
    Hoba, J.
    Kokot, K. E.
    Andritschke, M.
    Boeckel, J. -N.
    Laufs, U.
    EUROPEAN HEART JOURNAL, 2022, 43 : 3056 - 3056